Related Experiment Video
Updated: Jun 5, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas,
Michael Sand1, Thilo Gambichler, Daniel Sand
1Department of Dermatology and Allergology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany. michael.sand@ruhr-uni-bochum.de
Abstract:
Dicer is an essential cytosolic enzyme necessary for processing pre-microRNAs into mature microRNAs (miRNAs). Although a variety of malignancies have been attributed to perturbations in the miRNA machinery, there has been little research conducted on the role of miRNAs in cutaneous malignant melanoma and its premalignant lesions. In this small pilot study, we therefore investigated the distribution of Dicer by immunohistochemistry in cutaneous malignant melanomas, as well as in benign and dysplastic melanocytic nevi. Dicer was assessed in ten cutaneous malignant melanomas (CMM), benign melanocytic nevi (BMN), and dysplastic melanocytic nevi (DMN), by standard immunohistochemical staining. Semiquantitative analyses determined expression indices (EIs), which associate the conventional area fraction of labeled cells with immunostaining intensity scores, based on visual qualitative examination by two independent observers. Mean EI scores were significantly higher in the CMM group compared to those in the BMN group (p < 0.05). However, EI differences between BMN and DMN as well as between CMM and DMN were not significant (p > 0.05). For CMM we observed a significant correlation of Breslow tumor thickness and Dicer EI (r = 0.84, p = 0.022). For all three groups investigated, Dicer-positive staining was primarily located in the epidermis, specifically in melanocytes. By immunohistochemistry, Dicer staining was significantly higher in melanoma cells than in benign melanocytes. This preliminary study indicates that alterations in the miRNA machinery could exist and should be subject of further investigation.
Insights
Dicer enzyme levels are significantly higher in cutaneous malignant melanoma (CMM) compared to benign melanocytic nevi (BMN). This suggests altered microRNA processing may play a role in melanoma development, warranting further investigation into miRNA machinery in skin cancer.
Area of Science:
- Molecular Biology
- Oncology
- Dermatology
Background:
- MicroRNAs (miRNAs) are crucial for gene regulation, and their dysregulation is linked to various cancers.
- The role of miRNAs and associated enzymes like Dicer in cutaneous malignant melanoma (CMM) and its precursors remains under-investigated.
- Dicer is a key enzyme in processing pre-miRNAs into mature miRNAs.
Purpose of the Study:
- To investigate the expression and distribution of Dicer in CMM, benign melanocytic nevi (BMN), and dysplastic melanocytic nevi (DMN).
- To explore potential correlations between Dicer expression and clinicopathological features of melanoma.
Main Methods:
- Immunohistochemistry was used to assess Dicer distribution in 10 CMM, BMN, and DMN samples.
- Semiquantitative analysis determined Dicer expression indices (EIs) based on staining intensity and cell labeling.
- Statistical analyses, including t-tests and correlation analysis, were performed.
Main Results:
- Mean Dicer EI scores were significantly higher in CMM compared to BMN (p < 0.05).
- No significant differences in EI were found between BMN and DMN, or between CMM and DMN.
- A significant positive correlation was observed between Breslow tumor thickness and Dicer EI in CMM (r = 0.84, p = 0.022).
- Dicer staining was predominantly localized to epidermal melanocytes in all groups, with higher intensity in melanoma cells.
Conclusions:
- Dicer expression is significantly elevated in CMM compared to benign nevi.
- These findings suggest that alterations in the miRNA processing machinery, specifically Dicer, may be involved in melanoma pathogenesis.
- Further research is warranted to elucidate the precise role of miRNA machinery in melanoma development and progression.
Related Concept Videos
MicroRNAs
MicroRNAs
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

